Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Patent
1993-10-08
1995-08-08
Lacey, David L.
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
5303882, C07K 1528, C12P 2108
Patent
active
054400201
ABSTRACT:
There is provided a novel monoclonal antibody fragment which inhibits platelet function and may be useful in the treatment of thrombotic diseases. The fragment is produced by proteolytic digestion of the 7E3 monoclonal antibody.
REFERENCES:
patent: 5225181 (1993-07-01), Srivasta et al.
Marchalonis et al. Antibody as a Tool John Wiley; pp. 224, 465 1982).
Vainchecker et al. Blod 59(3): 514-21 (1982).
Coller Blood 58 (Suppl.) p. 191(a) Abstract 674 (1981).
Thrlow et al. Br. J. Haematol 55(1): 123-34 (1983).
Pidard et al. J Biol Chem 258(2): 12581-6 (1983).
Coller et al. J Clin Invest. 72:325-338 (1983).
Jones et al. Br. J. Haematol 57: 621-631 (1984).
Coller J Clin Invest 76: 101-108 (1985).
Gambel Phillip
Lacey David L.
The Research Foundation of State University of New York
LandOfFree
Platelet function inhibiting monoclonal antibody fragment does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Platelet function inhibiting monoclonal antibody fragment, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Platelet function inhibiting monoclonal antibody fragment will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-972269